Related references
Note: Only part of the references are listed.Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives
Ana Beleza-Meireles et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Non-Cell-Autonomous Effect of Human SOD1G37R Astrocytes on Motor Neurons Derived from Human Embryonic Stem Cells
Maria C. N. Marchetto et al.
CELL STEM CELL (2008)
Awareness of hormesis will enhance future research in basic and applied neuroscience
Mark P. Mattson
CRITICAL REVIEWS IN TOXICOLOGY (2008)
Hormesis and Adaptive Cellular Control Systems
Qiang Zhang et al.
Dose-Response (2008)
Management of amyotrophic lateral sclerosis
Philippe Corcia et al.
DRUGS (2008)
Hormesis: Why it is important to toxicology and toxicologists
Edward J. Calabrese
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2008)
Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS
Bernadett Kalmar et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
MUSCLE & NERVE (2008)
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Koji Yamanaka et al.
NATURE NEUROSCIENCE (2008)
Dyslipidemia is a protective factor in amyotrophic lateral sclerosis
L. Dupuis et al.
NEUROLOGY (2008)
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
E. J. Sorenson et al.
NEUROLOGY (2008)
Lithium delays progression of amyotrophic lateral sclerosis
Francesco Fornai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Vacuolization correlates with spin-spin relaxation time in motor brainstem nuclei and behavioural tests in the transgenic G93A-SOD1 mouse model of ALS
Selina Bucher et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS
Hans-Joerg Habisch et al.
EXPERIMENTAL NEUROLOGY (2007)
Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis
J. H. Veldink et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS
Christine Haenggeli et al.
NEUROBIOLOGY OF DISEASE (2007)
Onset and progression in inherited ALS determined by motor neurons and microglia
Severine Boillee et al.
SCIENCE (2006)
The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice
B Schütz et al.
JOURNAL OF NEUROSCIENCE (2005)
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study
M Graf et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit
R Kunert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis
M Kiaei et al.
EXPERIMENTAL NEUROLOGY (2005)
Vitamin E intake and risk of amyotrophic lateral sclerosis
A Ascherio et al.
ANNALS OF NEUROLOGY (2005)
Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice
D Kieran et al.
NATURE MEDICINE (2004)
Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model
S Waibel et al.
JOURNAL OF NEUROLOGY (2004)
Evidence for defective energy homeostasis in amyotrophic lateral sclerosis:: benefit of a high-energy diet in a transgenic mouse
L Dupuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice
AM Clement et al.
SCIENCE (2003)
Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis
DN Angelov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
An outcome study of riluzole in amyotrophic lateral sclerosis - A population-based study in Ireland, 1996-2000
BJ Traynor et al.
JOURNAL OF NEUROLOGY (2003)
Efficient three-drug cocktail for disease induced by mutant superoxide dismutase
J Kriz et al.
ANNALS OF NEUROLOGY (2003)
Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS
WH Zhang et al.
ANNALS OF NEUROLOGY (2003)
Minocycline slows disease progression in a mouse model of arnyotrophic lateral sclerosis
J Kriz et al.
NEUROBIOLOGY OF DISEASE (2002)
Minocycline delays disease onset and mortality in a transgenic model of ALS
L Van Den Bosch et al.
NEUROREPORT (2002)
A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis
C Desnuelle et al.
AMYOTROPHIC LATERAL SCLEROSIS (2001)
Share Paper
